Sylvia Schuepbach Sylvia Schuepbach

Specialist advertising

Compliance and sensitization field service

After updating its product advertising for doctors, a marketing authorization holder requested a legal review of the brochures and documents. We ensured that the advertising content complied with the pharmaceutical advertising regulations and was in line with the information for healthcare professionals.

Compliance and sensitization field service

After updating its product advertising for doctors, a marketing authorization holder requested a legal review of the brochures and documents. We ensured that the advertising content complied with the pharmaceutical advertising regulations and was in line with the information for healthcare professionals. With our many years of experience in advising on pharmaceutical advertising, both for specialists and for the general public, we support marketing departments and the sales force in expanding pharmaceutical advertising compliance with pragmatic solutions.

Read more
Sylvia Schuepbach Sylvia Schuepbach

From A to B via CH

International pharmaceutical distribution

An internationally active pharmaceutical company based in Switzerland handles the Europe-wide distribution of its medicinal products from Switzerland. The task was to clarify the conditions under which direct deliveries between EU countries with administrative processing via Switzerland are possible and...

International pharmaceutical distribution

An internationally active pharmaceutical company based in Switzerland handles the Europe-wide distribution of its medicinal products from Switzerland. It was necessary to clarify the conditions under which direct deliveries between EU countries with administrative processing via Switzerland are possible and which authorizations are required for this. All players in the pharmaceutical supply chain must comply with the principles of Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) in order to protect patients from falsified medicinal products entering the legal supply chain. With our experience in Swiss and European pharmaceutical law and in matters relating to bilateral agreements (Mutual Recognition Agreement, MRA), we were able to contribute to the design of the distribution structure.

Read more